Michael Gehring

SCHOTT AG engages in the production and distribution of specialty glass and glass ceramics. Its products are used in the consumer electronics, pharmaceutical, defense and security, optics, life sciences, energy and environment, automotive, and aviation industries. The company was founded by Otto Schott, Ernst Abbe, Carl Zeiss and Roderich Zeiss in 1884 and is headquartered in Mainz, Germany.

IKB Invest GmbH (IKB-PE) is the private equity arm and a wholly-owned subsidiary of IKB Deutsche Industriebank AG (FR: IKB). The bank's activities include domestic corporate lending, real estate finance, structured finance, private equity, treasury and financial markets. KfW holds a significant minority interest in the IKB group, and both banks have established a strategic partnership. Another significant shareholder is Stiftung Industrieforschung, a foundation established in 1974 following the merger between IKB-Industriekreditbank and Deutsche Industriebank, for the purpose of promoting commercial enterprise. Established in 1987, IKB-PE is headquartered in Dusseldorf, Germany.

LBBW Venture Capital GmbH (LBBW-VC) is part of the private equity arm and a wholly-owned subsidiary of LBBW-Landesbank Baden-Württemberg, a government-controlled regional bank based in southwestern Germany. Significant minority shareholders in LBBW include regional financial institutions and local government entities. LBBW-VC was established in 2000 and is headquartered in Stuttgart. The firm specializes in venture capital investing.

LEA Partners GmbH (LEA) is the private equity arm of Landeskreditbank Baden-Württemberg-Förderbank, itself a subsidiary of Landesbank Baden-Württemberg. The firm was founded in 2002 and is headquartered in Karlsruhe, Germany.

Robert Bosch Venture Capital GmbH (RBVC) is the corporate venture capital arm of the privately-held global company Robert Bosch GmbH, itself a subsidiary of Robert Bosch Stiftung GmbH. The firm is headquartered in Gerlingen, Germany, with another German office in Frankfurt, and international offices in Israel, China, and the US. The firm was established in 2007.

CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany.

S-KAP Unternehmensbeteiligungs GmbH & Co. KG provides investment and financing support services. The firm invests in and develops start-up and established companies in the medical technology, food manufacturing, construction, elderly care, and engineering service sectors. The company operations areas encompass equity capital management, financial restructuring, budget optimization, liquidation management, network expansion, business consulting and market presence establishment. It engages in open investment, capital financing, subordinated loans, and silent partnership agreements. S-KAP Unternehmensbeteiligungs is headquartered in Pforzheim, Germany.

Dr. Engelhardt, Kaupp, Kiefer Unternehmensbeteiligungen GmbH is an investment holding German company. The private company is based in Stuttgart, Germany. and has subsidiaries in Germany. The CEOs of the company are Stefan Mertel, Tobias Engelhardt, Roman Loch.

Bürgschaftsbank Baden-Württemberg GmbH is a German company that provides financing and funding solutions to medium-sized companies. The company is based in Stuttgart, Germany, and has subsidiaries in Germany. The private company helps businesses with growth, foundation, succession, and stabilization through solid financing. The company offers tailor-made solutions with default guarantees and participation capital, and they take part of the risk as a neutral partner. The company was founded in 1950, and the CEOs are Guy Selbherr and Dirk Buddensiek.